BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 34755921)

  • 1. Differences of adrenal-derived androgens in 5α-reductase deficiency versus androgen insensitivity syndrome.
    Han B; Zhu H; Yao H; Ren J; O'Day P; Wang H; Zhu W; Cheng T; Auchus RJ; Qiao J
    Clin Transl Sci; 2022 Mar; 15(3):658-666. PubMed ID: 34755921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profiling adrenal 11β-hydroxyandrostenedione metabolites in prostate cancer cells, tissue and plasma: UPC
    du Toit T; Bloem LM; Quanson JL; Ehlers R; Serafin AM; Swart AC
    J Steroid Biochem Mol Biol; 2017 Feb; 166():54-67. PubMed ID: 27345701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 11β-hydroxyandrostenedione, the product of androstenedione metabolism in the adrenal, is metabolized in LNCaP cells by 5α-reductase yielding 11β-hydroxy-5α-androstanedione.
    Swart AC; Schloms L; Storbeck KH; Bloem LM; Toit Td; Quanson JL; Rainey WE; Swart P
    J Steroid Biochem Mol Biol; 2013 Nov; 138():132-42. PubMed ID: 23685396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in
    Akcan N; Uyguner O; Baş F; Altunoğlu U; Toksoy G; Karaman B; Avcı Ş; Yavaş Abalı Z; Poyrazoğlu Ş; Aghayev A; Karaman V; Bundak R; Başaran S; Darendeliler F
    J Clin Res Pediatr Endocrinol; 2022 Jun; 14(2):153-171. PubMed ID: 35135181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights into 5α-reductase type 2 deficiency based on a multi-centre study: regional distribution and genotype-phenotype profiling of
    Gui B; Song Y; Su Z; Luo FH; Chen L; Wang X; Chen R; Yang Y; Wang J; Zhao X; Fan L; Liu X; Wang Y; Chen S; Gong C
    J Med Genet; 2019 Oct; 56(10):685-692. PubMed ID: 31186340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic accuracy of human chorionic gonadotropins (HCG) stimulation test in XY-disorders of sex development (XY-DSD) presented in Armed Forces Institute of Pathology.
    Sheikh WH; Asif N; Haroon ZH; Ejaz A; Ain QU; Shehzad N
    J Pak Med Assoc; 2019 Aug; 69(8):1090-1093. PubMed ID: 31431758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical, Hormonal, and Genetic Characteristics of 5α-Reductase Type 2 Deficiency in 103 Chinese Patients.
    Liu Q; Yin X; Li P
    Endocr Pract; 2022 Sep; 28(9):859-866. PubMed ID: 35700942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic variation in a family with partial androgen insensitivity syndrome explained by differences in 5alpha dihydrotestosterone availability.
    Boehmer AL; Brinkmann AO; Nijman RM; Verleun-Mooijman MC; de Ruiter P; Niermeijer MF; Drop SL
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1240-6. PubMed ID: 11238515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ANDROGEN INSENSITIVITY SYNDROME,REVIEW OF LITERATURE BASED ON CASE REPORTS.
    Markosyan R; Volevodz N
    Georgian Med News; 2020 Oct; (307):154-157. PubMed ID: 33270595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of pre- and post-pubertal dihydrotestosterone treatment on penile length in 5α-reductase type 2 deficiency.
    Sasaki G; Ishii T; Hori N; Amano N; Homma K; Sato S; Hasegawa T
    Endocr J; 2019 Sep; 66(9):837-842. PubMed ID: 31178538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenatal testosterone and theory of mind development: Findings from disorders of sex development.
    Khorashad BS; Khazai B; Roshan GM; Hiradfar M; Afkhamizadeh M; van de Grift TC
    Psychoneuroendocrinology; 2018 Mar; 89():250-255. PubMed ID: 29398092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inefficient UGT-conjugation of adrenal 11β-hydroxyandrostenedione metabolites highlights C11-oxy C
    du Toit T; Swart AC
    Mol Cell Endocrinol; 2018 Feb; 461():265-276. PubMed ID: 28939401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and molecular characterization of 5α-reductase type 2 deficiency due to mutations (p.Q6X, p.R246Q) in SRD5A2 gene.
    Jia W; Zheng D; Zhang L; Li C; Zhang X; Wang F; Guan Q; Fang L; Zhao J; Xu C
    Endocr J; 2018 Jun; 65(6):645-655. PubMed ID: 29643321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex Differences in 11-Oxygenated Androgen Patterns Across Adulthood.
    Davio A; Woolcock H; Nanba AT; Rege J; O'Day P; Ren J; Zhao L; Ebina H; Auchus R; Rainey WE; Turcu AF
    J Clin Endocrinol Metab; 2020 Aug; 105(8):e2921-9. PubMed ID: 32498089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotype and molecular characteristics in 45 Chinese children with 5α-reductase type 2 deficiency from South China.
    Cheng J; Lin R; Zhang W; Liu G; Sheng H; Li X; Zhou Z; Mao X; Liu L
    Clin Endocrinol (Oxf); 2015 Oct; 83(4):518-26. PubMed ID: 25899528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practical approach to steroid 5alpha-reductase type 2 deficiency.
    Cheon CK
    Eur J Pediatr; 2011 Jan; 170(1):1-8. PubMed ID: 20349245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profiles of 5α-Reduced Androgens in Humans and Eels: 5α-Dihydrotestosterone and 11-Ketodihydrotestosterone Are Active Androgens Produced in Eel Gonads.
    Yazawa T; Inaba H; Imamichi Y; Sekiguchi T; Uwada J; Islam MS; Orisaka M; Mikami D; Ida T; Sato T; Miyashiro Y; Takahashi S; Khan MRI; Suzuki N; Umezawa A; Kitano T
    Front Endocrinol (Lausanne); 2021; 12():657360. PubMed ID: 33833737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotype-phenotype correlation, gonadal malignancy risk, gender preference, and testosterone/dihydrotestosterone ratio in steroid 5-alpha-reductase type 2 deficiency: a multicenter study from Turkey.
    Abacı A; Çatlı G; Kırbıyık Ö; Şahin NM; Abalı ZY; Ünal E; Şıklar Z; Mengen E; Özen S; Güran T; Kara C; Yıldız M; Eren E; Nalbantoğlu Ö; Güven A; Çayır A; Akbaş ED; Kor Y; Çürek Y; Aycan Z; Baş F; Darcan Ş; Berberoğlu M
    J Endocrinol Invest; 2019 Apr; 42(4):453-470. PubMed ID: 30132287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 11β-Hydroxydihydrotestosterone and 11-ketodihydrotestosterone, novel C19 steroids with androgenic activity: a putative role in castration resistant prostate cancer?
    Storbeck KH; Bloem LM; Africander D; Schloms L; Swart P; Swart AC
    Mol Cell Endocrinol; 2013 Sep; 377(1-2):135-46. PubMed ID: 23856005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Childhood Sex-Typed Behavior and Gender Change in Individuals with 46,XY and 46,XX Disorders of Sex Development: An Iranian Multicenter Study.
    Khorashad BS; Roshan GM; Reid AG; Aghili Z; Moghadam MD; Khazai B; Hiradfar M; Afkhamizadeh M; Ghaemi N; Talaei A; Abbaszadegan MR; Aarabi A; Dastmalchi S; Van de Grift TC
    Arch Sex Behav; 2018 Nov; 47(8):2287-2298. PubMed ID: 30128981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.